These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice? Kristan SS Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):469-81. PubMed ID: 23703244 [TBL] [Abstract][Full Text] [Related]
3. Overview of cardiac markers in heart disease. Jarolim P Clin Lab Med; 2014 Mar; 34(1):1-14, xi. PubMed ID: 24507783 [TBL] [Abstract][Full Text] [Related]
4. Letter by Iles and Taylor regarding article, "Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume". Iles LM; Taylor AJ Circ Cardiovasc Imaging; 2013 Jul; 6(4):e25. PubMed ID: 23861456 [No Abstract] [Full Text] [Related]
5. The role of cardiac fibroblasts in extracellular matrix-mediated signaling during normal and pathological cardiac development. Sullivan KE; Black LD J Biomech Eng; 2013 Jul; 135(7):71001. PubMed ID: 23720014 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers of the extracellular matrix and of collagen fragments. Chalikias GK; Tziakas DN Clin Chim Acta; 2015 Mar; 443():39-47. PubMed ID: 25007952 [TBL] [Abstract][Full Text] [Related]